“The ISPE Pharma 4.0 SIG team is proud to receive this award. This article is a great collaborative work, with contributions from SIG members; it reflects the start of a practical road map for applying digitalization and Industry 4.0 in the pharmaceutical industry,” said the team.
“We look forward to developing the "holistic control strategy" concept, based on ICH standards, to bring digital maturity and data integrity by design into the pharmaceutical value network and enable flexible pharmaceutical manufacturing.”
The 2017 Winner was announced in the Editor's Voice article printed in the March/April 2018 issue of Pharmaceutical Engineering.
The article is the first in the award’s history in which the judges’ decision was unanimous. This speaks to the strategic thinking showcased in the article: equal parts innovation, pragmatism, and measurable goals.
Anna Maria di Giorgio, Editor in Chief
ABOUT THE ROGER F. SHERWOOD ARTICLE OF THE YEAR AWARD
Pharmaceutical Engineering has established an "Article of the Year" award to recognize the contribution of authors. Articles are evaluated by a panel of volunteer reviewers according to a number of criteria, concentrating on the importance and timeliness of the subject matter and the quality of the presentation.
As the world’s second largest market for pharmaceuticals and accounting for 20% of global medical device sales with double digit annual growth, the Chinese market is poised to have a significant impact on expanding patient access to innovative therapies and combination products (CPs). 1
1Chinese Medical Device Industry: How to thrive in an increasingly competitive market?
Digital transformation is the novel use of digital technology, including instrumentation and control systems, to solve traditional problems in a transformative manner. These digital solutions enable inherently new types of innovation and creativity, rather than simply enhancing, and supporting traditional methods.